Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on May 27, 2025
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Leadership Team Additions Strengthen Oncology and Real World Evidence Services for Sciensus
EIN Presswire
·
May 27, 2025
LONDON , UNITED KINGDOM, May 27, 2025 /EINPresswire.com/ -- Sciensus, a leading European life sciences organisation, providing access to medicines for European patients, is pleased to announce the appointment of Mark Hawken, Managing Director, Cancer …
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
GlobeNewswire
·
May 27, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging …
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City …
NI Holdings, Inc. Announces Executive Leadership Appointments
GlobeNewswire
·
May 27, 2025
FARGO, N.D., May 27, 2025 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (the “Company”, NASDAQ: NODK) today announced several strategic leadership appointments to support the company’s long-term growth and execution of its core business strategies. “We are excited …
Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
GlobeNewswire
·
May 27, 2025
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review updated data from the global …
Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
GARDNER, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it …
Dentsply Sirona Declares Quarterly Cash Dividend
GlobeNewswire
·
May 27, 2025
CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate …
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire
·
May 27, 2025
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an …
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Jason Okazaki, chief executive …
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
GlobeNewswire
·
May 27, 2025
SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new research studies at the 2025 ASCO Annual Meeting, including …
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
GlobeNewswire
·
May 27, 2025
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the …
HealthLink Dimensions Releases 2025 Physician Communications Report
EIN Presswire
·
May 27, 2025
Data Reveals Evolving Preferences, Digital Adoption, and Demand for Clinical Relevance ATLANTA, GA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- HealthLink Dimensions has published its 2025 Physician Communications Report, offering critical …
Burble Creativity Announces Sponsorship of Spectrum 360’s 2025 Walk for a Lifetime Supporting the Autism Community
EIN Presswire
·
May 27, 2025
The event will take place on Sunday, June 1, 2025, at Verona Park, bordered by Lakeside and Bloomfield Avenues in the southern part of Verona, NJ. MURRIETA, CA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Burble Creativity, a leading innovator in …
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire
·
May 27, 2025
Company announcement – No. 13 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 – Zealand Pharma A/S ("the …
Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
GlobeNewswire
·
May 27, 2025
Daix (France), New York City (New York, United States), May 27, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …
Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
GlobeNewswire
·
May 27, 2025
Daix (France), New York City (New York, Etats-Unis), le 27 mai 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …
Impelsys Launches mon’k AI Hub: Context-Aware Content Automation with a Human Touch
EIN Presswire
·
May 27, 2025
With advanced LLM-SLM architecture, AWS scalability, and editorial oversight, mon’k transforms content workflows without system overhauls. NEW YORK, NY, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Impelsys, a global technology leader, announces …